FR2669338B1 - - Google Patents

Info

Publication number
FR2669338B1
FR2669338B1 FR9014519A FR9014519A FR2669338B1 FR 2669338 B1 FR2669338 B1 FR 2669338B1 FR 9014519 A FR9014519 A FR 9014519A FR 9014519 A FR9014519 A FR 9014519A FR 2669338 B1 FR2669338 B1 FR 2669338B1
Authority
FR
France
Prior art keywords
peptide
fiv
env
protein
feline immunodeficiency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9014519A
Other languages
English (en)
French (fr)
Other versions
FR2669338A1 (fr
Inventor
Alexandre Avrameas
Gerard Guillet Jean
Anne Moraillon
Donny Strosberg Arthur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR9014519A priority Critical patent/FR2669338A1/fr
Priority to PCT/FR1991/000917 priority patent/WO1992009632A1/fr
Priority to DE69130457T priority patent/DE69130457T2/de
Priority to EP92900187A priority patent/EP0564477B1/fr
Priority to AT92900187T priority patent/ATE172983T1/de
Publication of FR2669338A1 publication Critical patent/FR2669338A1/fr
Application granted granted Critical
Publication of FR2669338B1 publication Critical patent/FR2669338B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K16/114—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR9014519A 1990-11-21 1990-11-21 Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline. Granted FR2669338A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR9014519A FR2669338A1 (fr) 1990-11-21 1990-11-21 Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
PCT/FR1991/000917 WO1992009632A1 (fr) 1990-11-21 1991-11-20 Fragments de la proteine env du virus de l'immunodeficience feline, anticorps et leurs applications dans le diagnostic
DE69130457T DE69130457T2 (de) 1990-11-21 1991-11-20 Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik
EP92900187A EP0564477B1 (fr) 1990-11-21 1991-11-20 Fragments de la proteine env du virus de l'immunodeficience feline, anticorps et leurs applications dans le diagnostic
AT92900187T ATE172983T1 (de) 1990-11-21 1991-11-20 Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9014519A FR2669338A1 (fr) 1990-11-21 1990-11-21 Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.

Publications (2)

Publication Number Publication Date
FR2669338A1 FR2669338A1 (fr) 1992-05-22
FR2669338B1 true FR2669338B1 (enExample) 1995-03-03

Family

ID=9402430

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9014519A Granted FR2669338A1 (fr) 1990-11-21 1990-11-21 Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.

Country Status (5)

Country Link
EP (1) EP0564477B1 (enExample)
AT (1) ATE172983T1 (enExample)
DE (1) DE69130457T2 (enExample)
FR (1) FR2669338A1 (enExample)
WO (1) WO1992009632A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591572A (en) * 1991-06-14 1997-01-07 St. Vincents Institute Of Medical Research Limited Detection of mammalian immunodeficiency viruses
FR2692270A1 (fr) * 1992-06-16 1993-12-17 Centre Nat Rech Scient Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.
ATE278018T1 (de) * 1992-06-16 2004-10-15 Centre Nat Rech Scient Nukleotid- und peptidsequenzen des immunschwächevirus der katze, isolat wo und anwendungen der sequenzen in der diagnostik und zur verhinderung der infektion
FR2692269B1 (fr) * 1992-06-16 1995-05-19 Centre Nat Rech Scient Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.
FR2692279B1 (fr) * 1992-06-16 1995-05-19 Centre Nat Rech Scient Séquences nucléotidiques issues de la souche WO du vif et leurs fragments, applications desdites séquences à l'expression de peptides immunogènes et au diagnostic de l'immunodéficience féline.
GB9215232D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9215233D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9219936D0 (en) * 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
EP0670901A1 (en) * 1993-03-11 1995-09-13 Akzo Nobel N.V. Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
US5849303A (en) * 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
FR2769916B1 (fr) * 1997-10-17 2000-12-01 Centre Nat Rech Scient Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
WO2005026733A1 (en) 2003-09-11 2005-03-24 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
AU2005267607B8 (en) 2003-09-11 2009-07-16 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP1709447B1 (en) * 2003-12-18 2009-06-24 Idexx Laboratories, Inc. Method for detecting feline immunodeficiency virus
AU2005215629B2 (en) * 2004-02-19 2009-01-29 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP1761556A1 (en) 2004-06-30 2007-03-14 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP2553452B1 (en) 2010-04-02 2015-03-04 IDEXX Laboratories, Inc. Detection of feline immunodeficiency virus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219725A (en) * 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
EP0471752A4 (en) * 1989-05-08 1992-09-02 Idexx Corp. Polypeptides of feline t-cell lymphotropic lentivirus

Also Published As

Publication number Publication date
WO1992009632A1 (fr) 1992-06-11
EP0564477B1 (fr) 1998-11-04
EP0564477A1 (fr) 1993-10-13
DE69130457T2 (de) 1999-05-27
ATE172983T1 (de) 1998-11-15
FR2669338A1 (fr) 1992-05-22
DE69130457D1 (de) 1998-12-10

Similar Documents

Publication Publication Date Title
FR2669338B1 (enExample)
ES2099066T3 (es) Antigenos a partir de adn sintetico derivado del virus de la inmunodeficiencia humana (hiv-1).
DE69333802T8 (de) Äusseres membranprotein von haemophilus
EP1475442A3 (en) Polypeptides of feline T-cell lymphotropic lentivirus
ATE175446T1 (de) Immunogene peptide, antikörper sowie deren verwendungen im zusammenhang mit der cd4- rezeptorbindung
EP0175360A3 (en) Peptide antibodies and their use in detecting oncogene products
AU1986588A (en) Growth hormone receptor
ES2010727A6 (es) Metodo para producir lineas celulares que producen anticuerpos monoclonales reactivos frente a determinantes antigenicos de gp110 o de p25 de hiv.
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
TR199800912T2 (xx) T�m�r a��s� ve a��n�n haz�rlanmas� i�in usul.
DE68928834D1 (de) Monoklonale antikörper gegen katzen-t-lymphotropes lentivirus
DK0614980T3 (da) Trans-dominante TAT-varianter fra humant immundeficiens-virus
DE69114339T2 (de) Verfahren zur Identifizierung oder Bestimmung von Proteinen und Verwendungen dazu.
ES2155821T3 (es) Toxinas quimericas mejoradas.
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
WO1995011975A3 (en) Retroviral superantigens, superantigen peptides, and methods of use
RU94045907A (ru) Вич-антитела человека или их фрагменты, экспрессионные кассеты, клетки-хозяева, фармацевтические композиции, способ защиты
EP0177814A3 (en) Peptide antibodies and their use in detecting oncogene products
DE3879881D1 (de) Rekombinante hiv-2 polypeptide.
AU3455693A (en) Peptides of the casein macropeptide, antibodies directed against said peptides, and applications
ATE119166T1 (de) An hiv relatierte peptide.
WO1989009227A3 (fr) Peptides pf10 a pf19 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation notamment pour le diagnostic
CA2134080A1 (en) Natural humain igm antibodies
AU4712993A (en) New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods
AU8976691A (en) Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof